Serological α1-antichymotrypsin in patients with probable senile dementia of Alzheimer type: A short-term longitudinal study

Alzheimer Disease and Associated Disorders

Volumn 10, Issue 4, 1996, Pages 192-196

  Licastro, Federico ^a,c   Davis, Lizabeth Jane ^a   Polazzi, Elisabetta ^a   Rossi, Sandra ^b   Cucinotta, Domenico ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Dipto di Patologia Sperimentale   (Italy)

Author keywords

Acute phase response; Alzheimer disease; Longitudinal study; Serum 1 antichymotrypsin

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; C REACTIVE PROTEIN; CERULOPLASMIN; MACROGLOBULIN; SERINE PROTEINASE INHIBITOR; TRANSFERRIN;

ACUTE PHASE RESPONSE; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; SENILE DEMENTIA;

EID: 0029850506     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199601040-00004     Document Type: Article

References (25)

1. Abraham CR, Selkoe DJ, Potter H. Immunochemical identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 1988;52:487-501.
2. 1-antichymotrypsin in brain dysfunction and injury. Res Immunol 1992;143:631-6.
3. 1-antichymotrypsin in Down's syndrome and Alzheimer's disease. Ann Neurol 1992;32:193-7.
4. 1-antichymotrypsin regulates Alzheimer β-amyloid peptide fibril formation. Proc Natl Acad Sci USA 1995;92:2313-7.
5. Folstein MF, Folstein SE, McHugh PR. "Mini mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
6. 1-antichymotrypsin binding to Alzheimer Aβ peptides is sequence specific and induces fibril disaggregation in vitro. J Neurochem 1993;61: 298-305.
7. Furby A, Leys D, Delacourte A, Buee L, Soetaert G, Petit H. Are alpha-1-antichymotrypsin and inter-alpha-trypsin inhibitor peripheral markers of Alzheimer's disease? J Neurol Neurosurg Psychiatry 1991;54:469.
8. Hinds TR, Kukull WA, Van-Belle G, Shellenberg GD, Villacres EC, Larson EB. Relationship between serum alpha 1-antichymotrypsin and Alzheimer's disease. Neurobiol Aging 1994;15:21-7.
9. 1-antichymotrypsin polymorphism. Nat Genet 1995;10:486-8.
10. Kang J, Lemaire HG, Unterbeck A, et al. The precursor of Alzheimer's disease A4 protein resembles a cell-surface receptor. Nature 1987;325: 733-6.
11. Kuiper MA, van-Kamp GJ, Bergmans PL, Scheltens P, Wolters EC. Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease. J Neural Trans Park Dis Dement Sect 1993;6:145-9.
12. 1-chymotrypsin. Alzheimer Dis Assoc Disord 1994;8:241-9.
13. 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer's disease. Alzheimer Dis Assoc Disord 1995a;9:112-8.
14. 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response. J Neuroimmunol 1995b;57:71-5.
15. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 1994;372:92-4.
16. Masters CL, Simms G, Weinmann NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc Natl Acad Sci USA 1985;82:4245-9.
17. Matsubara E, Hirai S, Amari M, et al. α-1-Antichymotrypsin as a possible biochemical marker for Alzheimer-type dementia. Ann Neurol 1990;28:561-7.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
19. Miyakawa T, Shimoji A, Kuramoto R, Higuchi Y. The relationship between senile plaques and cerebral blood vessels in Alzheimer's disease and senile dementia. Virchows Arch 1982;40:121-9.
20. 1-antichymotrypsin in hemopoietic and lymphoid tissue cells are revealed by immunoperoxydase method. Pathol Res Pract 1980;169:287-97.
21. 1-antichymotrypsin and IL-1β are not increased in CSF or serum in Alzheimer's disease. Neurobiol Aging 1994;15:313-7.
22. Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-9.
23. Talbot C, Houlden H, Craddock N, et al. Polymorphisim in AACT gene may lower the age of onset of Alzheimer's disease. NeuroReport 1996;7:534-6.
24. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Ann Rev Biochem 1983;52:655-709.
25. Wisniewski HM, Narang HK, Terry RD. Neurofibrillary tangles of paired helical filaments. J Neurol Sci 1976;27:173-81.